VAERS reports by lot

GSK Varicella/Shingles lot 9JG52: VAERS reports

55 VAERS reports list lot 9JG52 as a GSK Varicella/Shingles vaccine, received between 2019-06-29 and 2022-05-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
55
Reports
4%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3923%
General / Systemic (non-local)3521%
Dermatological (non-injection-site)3018%
Neurological2112%
Musculoskeletal1911%
Cardiac / Cardiovascular85%
Allergic / Anaphylactic74%
Gastrointestinal64%
Respiratory32%
Thrombotic / Hematological11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey5
California5
Wisconsin4
Pennsylvania4
South Carolina4
Texas4
Florida4
North Carolina3
Tennessee3
Washington2
New Mexico2
Ohio2

Reports by month received

2019-062
2019-0722
2019-0816
2019-097
2019-102
2019-121
2020-021
2020-031
2020-051
2020-111
2022-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.